DOI: https://doi.org/10.22141/2224-0551.15.4.2020.208470

The role of single nucleotide polymorphism TLR4 in the development of the non-alcoholic fatty liver disease in children

Yu.M. Stepanov, N.Yu. Zavhorodnia, O.I. Grabovska, I.A. Klenina, O.M. Tatarchuk

Abstract


Background. The TLR4 non-synonymous single nucleotide polymorphism (SNPs) changes the spatial structure and, probably, the sensitivity of the receptor to its ligands, determines the certain functional aberrations that can affect the nature and activity of inflammation. The purpose of the study was to exa­mine the associations of the SNP Asp299Gly rs4986790 of the TLR4 gene with liver structural changes, innate immunity, and carbohydrate metabolism parameters in children with NAFLD. Materials and methods. The study included 76 children with overweight and obesity aged 9 to 17 years. The presence of liver steatosis was determined using transient elastometry. According to the presence of liver steatosis, the children were divided into 2 groups; following the presence of SNP Asp299Gly (rs4986790) of the TLR4 gene, each group was divided into two subgroups: children with normal (Asp299Asp) and polymorphic (Asp299Gly) variants of the TLR4 gene. The blood serum content of insulin, IL-6, IL-10, TNF-α was determined by enzyme immunoassay, the HOMA-IR index was calculated. Results. The SNP Asp299Gly rs4986790 of the TLR4 gene detection rate in the heterozygous state among all children was 15.8 %, in children with NAFLD — 20.0 %, and in children without steatosis — 11.1 % (p > 0.05). Significant differences in the stiffness and degree of fatty liver in patients with AA and AG SNP rs4986790 genotypes were not found (p > 0.05). In children with NAFLD with the Asp299Gly variant of the TLR4 gene, the level of IL-10 was significantly higher compared to patients with the Asp299Asp variant of the TLR4 gene. At the same time, in children with the Asp299Asp variant without liver steatosis, a significantly higher level of IL-6 concentration was observed (p < 0.05) compared with individuals with the TLR4 gene Asp299Gly polymorphic variant. A moderate direct correlation was found between the Asp299Gly variant of the TLR4 gene and IL-10 level (r = 0.459, p < 0.05). In children with the Asp299Asp variant of the TLR4 gene with NAFLD, higher HOMA-IR values were observed compared to patients with the Asp299Asp variant of the TLR4 gene (p > 0.05). A direct correlation was found between the level of IL-6 and insulin (r = 0.398; p < 0.01), the HOMA-IR index (r = 0.364; p < 0.05) in children with NAFLD. Conclusions. Children with NAFLD and SNP Asp299Gly rs4986790 TLR4 are characterized by significantly higher levels of IL-10 production and lower levels of insulin and HOMA-IR, which may indicate the protective properties of the SNP Asp299Gly rs4986790 TLR4 in the NAFLD development and progression.

Keywords


single nucleotide polymorphism; toll-like receptor 4; non-alcoholic fatty liver disease; children

References


Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol. 2019;16(9):517-530. doi:10.1038/s41575-019-0169-z.

Fitzpatrick E. Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum. Proc Nutr Soc. 2019;78(3):362-371. doi:10.1017/S0029665118002914.

Stepanov YuM, Abaturov OYe, Zavgorodnia NYu, Skyrda ІYu. Non-Alcoholic Fatty Liver Disease in Children: Current View on Diagnostics and Treatment (Part I). Gastroenterologìa.2015;(56):99-107. doi:10.22141/2308-2097.2.56.2015.81504. (in Ukrainian).

Takaki A, Kawai D, Yamamoto K. Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2014;15(5):7352-7379. doi:10.3390/ijms15057352.

Stepanov YuM, Zavgorodnia NYu, Lukianenko OYu, Zygalo EV, Yagmur VB. Association of small intestinal bacterial overgrowth and non-alcoholic fatty liver disease in children. Gastroenterologìa. 2019;53(4):266-272. doi:10.22141/2308-2097.53.3.2019.182406.

Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000;25(2):187-191. doi:10.1038/76048.

García-Bermúdez M, López-Mejías R, González-Juanatey C, et al. Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. DNA Cell Biol. 2012;31(7):1214-1220. doi:10.1089/dna.2011.1582.

Agnese DM, Calvano JE, Hahm SJ, et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis. 2002;186(10):1522-1525. doi:10.1086/344893.

Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med. 2002;162(9):1028-1032. doi:10.1001/archinte.162.9.1028.

Vidyant S, Chatterjee A, Dhole TN. A single-nucleotide polymorphism in TLR4 is linked with the risk of HIV-1 infection. Br J Biomed Sci. 2019;76(2):59-63. doi:10.1080/09674845.2018.1559486.

Sellers RM, Payne JB, Yu F, LeVan TD, Walker C, Mikuls TR. TLR4 Asp299Gly polymorphism may be protective against chronic periodontitis. J Periodontal Res. 2016;51(2):203-211. doi:10.1111/jre.12299.

Moaaz M, Youssry S, Moaz A, Abdelrahman M. Study of Toll‑Like Receptor 4 Gene Polymorphisms in Colorectal Cancer: Correlation with Clinicopathological Features. Immunol Invest. 2020;49(5):571-584. doi:10.1080/08820139.2020.1716787.

Abaturov OYe, Gerasymenko ON, Shlykova OA, Kaidashev IP. Genetic Polymorphism of Toll-Like Receptor 4 ASP299GLY Gene Polymorphism in Children with Helicobacter pylori Infection. Zdorov'e rebenka. 2013;(49):14-18. doi:22141/2224-0551.6.49.2013.84834. (in Ukrainian).

Dubinska GM, Sizov LM, Koval TI, Shlykova OA. Prevalence of gene TLR4 Asp299Gly polymorphism among patients with chronic hepatitis C in Poltava region. Actual Problems of the Modern Medicine. 2015;15(1):81-84. (in Ukrainian).

Sizova LM. Peculiarities of clinical and laboratory characteristics of chronic hepatitis c in patients with polymorphism Asp299Gly of TLR4 gene and Gln11Leu of TLR7 gene. Actual Problems of the Modern Medicine. 2016;16(56):183-188. (in Ukrainian).

Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002;347(3):185-192. doi:10.1056/NEJMoa012673.

Lee YH, Bae SC, Song GG. Meta-analysis demonstrates association between TLR polymorphisms and rheumatoid arthritis. Genet Mol Res. 2013;12(1):328-334. doi:10.4238/2013.February.7.2.

Lee YH, Bae SC, Kim JH, Song GG. Toll-like receptor polymorphisms and rheumatoid arthritis: a systematic review. Rheumatol Int. 2014;34(1):111-116. doi:10.1007/s00296-013-2666-7.

Hajjar AM, Ernst RK, Yi J, Yam CS, Miller SI. Expression level of human TLR4 rather than sequence is the key determinant of LPS responsiveness. PLoS One. 2017;12(10):e0186308. doi:10.1371/journal.pone.0186308.

Wood MJ, Powell LW, Dixon JL, Subramaniam VN, Ramm GA. Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis. World J Gastroenterol. 2013;19(48):9366-9376. doi:10.3748/wjg.v19.i48.9366.

Ferwerda B, McCall MB, Alonso S, et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A. 2007;104(42):16645-16650. doi:10.1073/pnas.0704828104.

Kapil S, Duseja A, Sharma BK, et al. Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22(42):9346-9355. doi:10.3748/wjg.v22.i42.9346.

Kiziltas S, Ata P, Colak Y, et al. TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls. Metab Syndr Relat Disord. 2014;12(3):165-170. doi:10.1089/met.2013.0120.

Miura K, Ishioka M, Iijima K. The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease. J Obes Metab Syndr. 2017;26(2):86-96. doi:10.7570/jomes.2017.26.2.86.

Abaturov OYe, Gerasymenko ON. Modulation of activity TLR4 epithelial cells of the gastric mucosa at helicobacter pylori of infection (review of literature). Sovremennaia pediatriya. 2009;(28):141-146. (in Ukrainian).

Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019;76(1):99-128. doi:10.1007/s00018-018-2947-0.

Jin C, Henao-Mejia J, Flavell RA. Innate immune receptors: key regulators of metabolic disease progression. Cell Metab. 2013;17(6):873-882. doi:10.1016/j.cmet.2013.05.011.

Steinhardt AP, Aranguren F, Tellechea ML, et al. A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation. Metabolism. 2010;59(5):711-717. doi:10.1016/j.metabol.2009.09.015.

Chang WW, Zhang L, Jin YL, Yao YS. Toll-like receptor 4 gene Asp299Gly and Thr399Ile polymorphisms in type 2 diabetes mellitus: A meta-analysis of 15,059 subjects: Need for clarification of data in a recent meta-analysis. Diabetes Res Clin Pract. 2015;110(3):e31-e32. doi:10.1016/j.diabres.2015.08.001.

Weyrich P, Staiger H, Stančáková A, et al. The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies. PLoS One. 2010;5(11):e13980. doi:10.1371/journal.pone.0013980.






Copyright (c) 2020 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2020

 

   Seo анализ сайта